chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vertigo; dizziness; trembling; throwup; terrible right hip pain; A spontaneous report was received from a consumer who was also a 70-year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vertigo, dizziness, trembling/tremor, throw up/vomiting, terrible right hip pain/arthralgia.  The patient's medical history was not included. Products known to have been used by the patient were not provided.  On 12 February 2021, prior to the onset of the events, the patient received one of two planned doses of mRNA-1273 (Lot number: 031mz0) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 14 February 2021, approximately two days after the mRNA-1273 vaccine was given, the patient experienced vertigo, dizziness, trembling, and throw up. He reported being hospitalized for these symptoms.  On 16 February 2021, he reports that he is feeling much better, but is experiencing terrible hip pain.  Consent to contact was provided.  Treatment information was not provided.   Action taken with mRNA-1273 was not reported.  The outcome of the events, vertigo, dizziness, trembling, throw up, and terrible hip pain, were considered unknown.; Reporter's Comments: This case concerns a 70 year old male patient, who experienced a serious unexpected event of vertigo, dizziness, and tremor among others, 3 day after receiving first dose mRNA- 1273 (Lot# 031mz0). Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested.
Information has been received from a licensed practical nurse referring to a 43 year old female patient with Attention Deficit Disorder (ADD), environmental allergies and penicillin allergy. Before the vaccine was administered, an antibody test was drawn to the patient on unspecified date: Measles result was 0.90 (unit not provided) which reporting nurse said was okay, Mumps result was 0.2690 (unit not provided) low and Rubella was non-reactive. On 15-SEP-2014, the patient was vaccinated with a dose of MMR II, 0.5 ml, subcutaneous in the left arm (lot # K001230, expiration date 27-JAN-2016, dose number unknown). Concomitant therapies included alprazolam, dextroamphetamine, CYMBALTA, loratadine (manufacturer unknown) and zolpidem (manufacturer unknown). On 15-SEP-2014, almost immediately post vaccination, the patient developed soreness and achiness in her legs and arms and was unable to move her arms or legs. This occurred in both arms and both legs. No treatment was given to the patient and she never contacted the office with these symptoms. The events lasted for about 2 weeks and she recovered on approximately 29-SEP-2014. Additional information has been requested.
On 12/19  I woke with swelling to my right arm pit and no other symptoms at that time. Swelling moved over the right side of my body and a mild headache. At 10 pm on 12/19 the swelling was no different with soreness and a mild headache which I took two tylenol and slept most of the night. On 12/20 I had the same swelling, no pain, no fever, brusing on the right side of my body. I took two advil and two tylenol through out the day. The swelling and brusing changed. No fever just a mild headache. On 12/21 I woke with not swelling, more brusing, and a mild headache.  Under my right breast, there was a rash. I applied cream. The bruising was still there no swelling. The rash and brusing increased the next day. No fever or swelling. I was treated for Shingles at an Urgent Care.
SHORTNESS OF BREATH; CAN'T TAKE A DEEP BREATH; This spontaneous report received from a patient concerned a 5 decade old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient has allergies of unspecified drug. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 203A21A expiry: UNKNOWN) dose was not reported, administered on 14-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-MAY-2021, the subject experienced shortness of breath. On 14-MAY-2021, the subject experienced can't take a deep breath. The action taken with covid-19 vaccine  was not applicable. The patient was recovering from shortness of breath, and can't take a deep breath. This report was non-serious.
patient was given a syringe that had been opened 6+ hours previously and at room temperature the entirety of the time. Pfizer notified for guidance, as of this report, RN is waiting to hear back about guidance/next steps.
The patient was admitted to Hospital on 10/31/2016 with increase shortness of breath and O2 sat 64%. The patient is being treated for pneumonia. The patient then when into ARDS and required ventilation. The patient is still currently being treated at Hospital. He remains incubated and critically ill, he is now receiving dialysis. The patient's loved ones insist that the patient started to take a turn for the worse after he received the flu shot.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 16-DEC-2014 the patient was vaccinated with an expired dose of PNEUMOVAX 23 lot # J007060, expiration date 28-AUG-2014, dose 0.5 ml, intramuscular. No adverse experience reported. Additional information has been requested.
Lost taste; Lost smell; This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (Lost taste) and ANOSMIA (Lost smell) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced AGEUSIA (Lost taste) and ANOSMIA (Lost smell). At the time of the report, AGEUSIA (Lost taste) and ANOSMIA (Lost smell) outcome was unknown. Not Provided          concomitant medicines was not reported by reporter  treatment information was not provided The action taken with mRNA-1273 with the events was considered as not applicable     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded
Patient donated 879 mL of plasma and shortly after received Tdap injection (at 2:22 pm), Patient stayed at the center for 15 minutes with no reaction. Patient states that she walked to the bus and boarded a bus. Patient states that it was a very hot day and she walked over a mile to the bus depot before boarding the bus. Patient states that approximately 1 hour after she left the plasma center, she was standing on the bus and fainted and had no other symptoms. Patient is unsure how long she had LOC and a bystander called an ambulance. Donor states she was evaluated by paramedics, but it was not recommended by paramedics to be transported to the hospital. Patient states she has felt fine since regained consciousness.
It was reported that a female pt reportedly received an Imovax vaccination. Reportedly, on 7/7/99 and 7/10/99, the pt complained of pain for 2 days at the site of the injection, nausea and diarrhea. On 7/14/99, the pt complained of pain at the site of injection for 2 days. On 7/16/99, complained of redness, swelling and itching (at injection site) approx. 2" (in size). On 7/21/99, the pt complained of pain at the injection site for 2 days and on 7/23/99, complained of redness, swelling and itching approx. 5" (in size).
Sore at site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid left, administration date 19Jan2021 11:00 (Lot number: EL3302) at the age of 67 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "Sore at site".  Additional info: Patient received Dose 2 on 08Feb2021 and Dose 3 on 06Oct2021. Did not received any medication prior to Vaccinations (within 4 weeks).  No follow-up attempts are possible. No further information is expected.
Varicella vaccine given 12 mos of age (10/95). Now 8 yo severe onset of chicken pox high fevers over 200 chicken pox 1st night in ears-genitals around mouth all over face all over body as well over 40. Tx with Benadryl and Acyclovir. Day #4 pt still fever but lower. Acyclovir seems to hep was given within 24 hrs of onset.
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a patient who received SHINGRIX for prophylaxis. On 26th March 2019, the patient received the 2nd dose of SHINGRIX. In March 2019, less than a week after receiving SHINGRIX, the patient experienced influenza-like symptoms, feeling unwell and feeling bad. On an unknown date, the outcome of the influenza-like symptoms, feeling unwell and feeling bad were unknown. It was unknown if the reporter considered the influenza-like symptoms, feeling unwell and feeling bad to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient had the SHINGRIX vaccine on Tuesday in afternoon. The patient was having the flu like symptoms and felt awful. The patient was asking how long did this generally last.
REDNESS/INFLAMMING OF THE SITE OF INJECTION. FEVER. HEADACHE.
PATIENT HAD 2 COVID VACCINES IN 2021, CONTRACTED COVID-19 AND THEN TOOK A BOOSTER. 18 YEAR OLD WITH NO HEALTH CONDITIONS, NOW WITH CHRONIC ONGOING CHEST PAIN, ARRYTHMIAS, NEW DIAGNOSIS OF POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME
Myalgia chills, muscle spasms, sweating, headache, left arm soreness Narrative:  NA
Seizure like activity @ home approx 8 hrs after immunizations received-unresponsive to name-to local ER-had temp 102- septic workup negative per mother's report. Diagnosed w/febrile seizures. Had onset of gastroenteritis 4/19/07-Had repeat seizure at ER and recovered after incident.
Community acquired pneumonia. ED visit to hospital admission. This visit is within 6 weeks of receiving the COVID vaccine.
Hives in random places over body. Started 8 days after original shot. Started with itching. When I would scratch, hives would appear. After 2 days of intense itching, took an antihistamine. This stopped the itching. Took it for two days and itching has not returned.
After injection was completed intramuscularly in the left arm, the patient bled slightly and then the injection site and surrounding area started to react and swell. Not only was the swelling at the injection point, but there was redness and swelling around the injection point as well. Patient felt no pain or discomfort. Patient stated that she had reactions that consisted of a delayed rash and irritation around injection from the first 3 Moderna shots. Patient will continue to monitor the injection site, but has no concerns.
chills (8:30pm)  body aches  and  chills 12:00am, headache 2:00am, arm soreness
Face got dropped, was diagnosed with Bell's Palsy.   The only different thing in my life was the vax.  It still completely frozen up to now.
pain in the back of shoulders; pain in the left arm (no site of injection); pain in the left breast; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 28-Dec-2020, the patient experienced ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast).   The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) ongoing since an unknown date for Pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (pain in the back of shoulders), PAIN IN EXTREMITY (pain in the left arm (no site of injection)) and BREAST PAIN (pain in the left breast) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, X-ray: unknown Unknown.  For mRNA-1273 (COVID 19 Vaccine Moderna) administered intramuscularly, the reporter did not provide any causality assessments.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  Concomitant medication was not reported.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. Concomitant therapies included sterile diluent (manufacturer unknown). On 09-JAN-2019, the patient was vaccinated with one dose of improperly stored M-M-R II) lot # R000550 with expiration date on 08-JAN-2020 (exact dose and route of administration were not reported) for prophylaxis. The vaccine underwent temperature excursion of above 47 degrees Fahrenheit (48.9 degrees Fahrenheit) for 2 hours. There was no previous temperature excursion. The digital data logger was involved in recording excursion details. No adverse effect was reported.
arm sore at injection site, itchy, red bump at injection site, mild tenderness, warm like sensation at injection site. tiredness for the first 3days then felt fine, bump went away but came back on day 7 and started itching again
11/12/2021:pain left side of abdomen to left back 11/17/2021 11:30 AM: went to Dr, diagnosed possible diverticulitis  11/17/2021 Evening: Noticed rash on left front side of abdomen, treated with rash medicine 11/20/2021: Noticed rash on back 11/21/2021: Noticed rash moving from back to left fron 11/22/21: Went to Dr, diagnosed with Shingles, given prescription.
ABDOMINAL ABSCESSES; SURGERY MULTIPLE ISSUES; PERSONALITY CHANGES; INJURED; HOSPICE FOR PAIN; This spontaneous report received from a patient via Social media via a company representative concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on JUN-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date in DEC-2021 (reported as a 7 weeks ago), the patient experienced four abdominal abscesses and surgery multiple issues and was hospitalized. Number of days of hospitalization was not reported. On an unspecified date, the patient experienced personality changes, injured and hospice for pain. As per reporter "I have noticed personality changes. My dad is injured. Took the J &J 7 months ago. 7 weeks ago hospitalized with 4 abdominal abscesses. Surgery multiple issues now going to hospice for pain." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the personality changes, injured, abdominal abscesses, pain and surgery multiple issues was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20220118348-covid-19 vaccine ad26.cov2.s-s-abdominal abscesses, surgery multiple issues . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
At the beginning, Had glands in neck hurt, fever,     Later have chills, no fever, glands hurt, body aches,    Now, have sore throat, no fever, glands hurt, sinus infections, Now have mucus in chest (yellow) coughing up.
Patient states she got her flu shot on Friday when she was in for a routine follow up appointment. She says she was doing well until late Saturday-around 8pm. Numbness and tingling of the L arm, shortness of breath, anxiety, shaking, tachycardia, dryness of the mouth, and low back pain, this lasted for 1hour. Patient states that she took a soda and a tea to relax she says she feels better but the anxiety continues.  Per MD patient was called notifying her this was possible a reaction from the flu shot though it could have been something else. MD charted reaction to patient's chart and have her NOT get it again. Next season we can re-think about patient getting the shot again.
p/vax pt exp high pitched cry continuing at intermittent intervals; seen 6/12 w/2 starring episodes w/movement of both arms lasting one-two minutes;
This spontaneous report was received from a Licensed Practical Nurse (L.P.N), referring to a 2 year old male patient. The patient's medical history, concurrent conditions, concomitant therapies and drug or allergy reactions were not provided. On 03-APR-2018, the patient was vaccinated with a dose of improperly stored Oka/Merck VARIVAX (strength, dose, dose number and administration route were not reported) lot number N015477, expiration date 18-MAY-2018, for prophylaxis. Concomitant therapies included a properly stored sterile diluent used for reconstitution (lot number and expiration date were not reported). The vaccine was exposure to a temperature excursion; the data logger registered a temperature range between 6 grades Fahrenheit (°F) and 14°F for 15 hours. The previous temperature excursion registered was 6°F to 14°F for 48 hours. No adverse effects were reported. This is one of two reports received from the same reporter. Sender's Comments: US-009507513-1805USA012575.
pt recvd vax in 1993 & exp dec color, side, depth perception; dx w/optic neuritis;
Pt experienced dizziness approximately 10 minutes after his shot, while walking within the facility. He sat down and had some soda because  he had not eaten since breakfast and thought due to diabetes, may have had low bs. He felt worse after sitting for awhile at which time emergency services were called. He shared that he had a history of stroke. He was oriented and did not have any visible abnormalities but continued to feel dizzy and unwell and also reported numbness in his fingertips. I was unable to reach him for follow up.
This spontaneous report as received from a pharmacist refers to a 63 years old male patient with no pertinent medical history. The patient was vaccinated with ZOSTAVAX on an unspecified date 2 years ago. No other co-suspects were reported. No concomitant medications were reported. The patient has experienced several recurrent episodes of shingles since administration of ZOSTAVAX on an unspecified date 2 years ago. No treatment information was reported. The outcome of several recurrent episodes of shingles was reported as recovered/resolved. The relatedness for several recurrent episodes of shingles was unknown for ZOSTAVAX. Additional information has not been requested.
Throat swelling, difficulty swallowing, difficulty coughing, tight chest, red watery eyes, grainy feeling in eyes, eventual major swelling of skin around eyes.
First day and night, sore arm. Within past week up until today slight headache/migraine. Noticed today 10 days after vaccine, red patches on left arm where injection was given.  Note: vaccine given not by health clinic.
Started feeling slightly dizzy, lightheaded at 1535.  Thought it was the heat.  Then at 1545, after I had been observed and seen as ok, no reaction, feeling very very tired.  A little afterwards, when I got home, 1602, my throat had started to close up, had SOB, DOE, and extreme fatigue and imbalance and dizziness.  I immediately took 4 liquid zyrtec (40mg total--I didn't have my epi pen) and then the throat closing started feeling better.  2 hours after the vaccine, more or less, I started to have a temp 99.8, then soon after 100.5, and then spiked at 101.8 that same night with lots of chills.  I had arthralgia, myalgia, nausea, anorexia, sweats and night sweats, slight HA, and very very SOB and DOE.  I had loose stool (and continued nausea) on the 3rd day, and continued to Thurs and Friday, (days 5 and 6).  My fever still continued for 3 days straight, as well as my dizziness and imbalance for a week.  I just barely started feeling better, and less tired yesterday, so that I can attend church.  I was unable to drive much, as I couldn't concentrate, loss focus, and feeling very very Winded.  Even now, Today, Monday, 8x days after the JJ, I am feeling tired with mental and physical exertion.  Physical exertion is making myself a fried egg, taking out the eggs, mixing eggs, frying, and finish eating the egg and putting away the plate.  I still have sweats and night sweats, when I am the one always complaining of cold and turning off the fan, now, I am sweating like a pig.  I have appt with doctor scheduled this coming end of the month.  Was unable to go to seek medical attention for these symptoms 2nd to s/s
patient had 2 falls "both happened on Sundays"; headaches; chills; burning in joints; This spontaneous case was reported by a consumer and describes the occurrence of FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004C21A and 031B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VALSARTAN for Blood pressure high.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2021, the patient experienced FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, FALL (patient had 2 falls "both happened on Sundays"), HEADACHE (headaches), CHILLS (chills) and ARTHRALGIA (burning in joints) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitants include gummy vegetable supplement. Patient declined any symptoms after first dose.
mom states pt had very high fever & was having problems breathing; took pt to clinic & was told was allergic to pertussis vax;
Patient had a seizure. He began to look to the left and blink constantly. Seizure lasted 4 minutes.
I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 3/24/2021 ATHEROSCLEROSIS OF AORTA J96.00 ACUTE RESPIRATORY FAILURE 3/24/2021 ATHEROSCLEROSIS OF AORTA